Indirect infringement remains a key consideration in patent enforcement, particularly where patented technology is supplied, distributed, or implemented through complex commercial and international supply chains. As products and services increasingly involve multiple parties, questions concerning liability often extend beyond the direct infringer to suppliers, distributors, manufacturers, and other participants involved in the exploitation of a patented invention.
This category covers developments relating to indirect infringement, contributory infringement, and related forms of secondary liability in patent law. Our contributors analyse court decisions, legislative developments, and emerging litigation trends that shape the circumstances under which parties may be held liable for facilitating or enabling patent infringement.
Topics include the supply of essential means, knowledge and intent requirements, component and software-related inventions, online platforms, standard-essential patents (SEPs), and the growing body of case law emerging from the Unified Patent Court (UPC) and national courts. Particular attention is given to decisions that influence enforcement strategies, infringement assessments, and risk management for businesses operating across multiple jurisdictions.
For patent owners, in-house counsel, litigators, and other IP professionals, this section provides timely analysis of one of the most commercially significant and rapidly evolving aspects of patent litigation.
On 22 June 2010, the English Court of Appeal handed down its judgment in yet another case involving stents in Occlutech v. AGA Medical. The appeal was dismissed with the result that AGA’s patent was…
Control question: remember what this was?
You certainly knew the answer had you read Max’s post on Patent Law and Philosophy: this is not just an IBC (Intermediate Bulk Container) for acids and…
German courts (and German attorneys) have been quite creative to improve the position of the patentee in litigation in the past. Last year the Olanzapine- decision of the Appeals Court in Düsseldorf,…
I have to start this with a simple introduction into container technology:
This is an intermediate bulk container (IBC):
In principle such an IBC consists of three elements, the base, the outer…
On 18 June 2009 the IP Chamber of the Milan Court issued its official interpretation on whether the filing of an MA application for a generic drug when the patent is still in force results an act of…
The Austrian Supreme Court decided that a patent owner is free to base an infringement action on a limited version of its claims, irrespectively of initiating formal limitation proceedings.
An…
Whether patent holders marketing branded drugs may assume that the very act of filing of an MA application by generic companies result in patent infringement is one of the hottest issues at the…
On 1 March 2010, Commercial Court number 1 of Pamplona handed down a judgement dismissing a declaratory non-infringement action filed by L.C. against N. The Court rejected the claim in its entirety,…
The District Court of The Hague holds that in case of ambiguities in the claim language the skilled man will consult the prosecution history to determine the scope of protection. The patent can not…